Infant Formula Safety Modernization Act of 2026

This bill would require infant formula manufacturers to conduct standardized testing for specific pathogens and microorganisms in both their facilities and finished products. It mandates that companies report positive test results to the FDA within one business day and retain records of these findings for inspections. The legislation also requires the FDA to notify congressional committees within one business day of receiving positive test results or issuing certain inspection classifications. Additionally, the bill establishes clear inspection standards that apply to all infant formula products regardless of where they are made.